Increasing the effciency of spinal anesthesia in a cesarean section in pregnant women with diabetes mellitus-Reference-Cited by-同舟云学术

Increasing the effciency of spinal anesthesia in a cesarean section in pregnant women with diabetes mellitus

Published:2021-10-01 Issue:3 Volume: Page:33-41
ISSN:2708-6011
Container-title:Health and Ecology Issues
language:
Short-container-title:jour

Author:

Rymasheuski U. V.¹^ORCID,Kanus I. I.¹^ORCID,Aletski V. E.¹^ORCID

Affiliation:

1. Belarusian Medical Academy of Postgraduate Education

Abstract

Objective. To increase the effciency of spinal anesthesia (SA) in operative delivery of pregnant women with type 1 diabetes mellitus (DM).Materials and methods. A dynamic assessment of the clinical effciency of spinal anesthesia in cesarean sections was performed in 123 pregnant women with DM. The level of the sensor and motor block was determined depending on the dose of a 0.5% hyperbaric solution of bupivacaine calculated according to the original method.Results. The SA method in cesarean sections in pregnant women with diabetes mellitus has been proposed taking into account the dosage of a hyperbaric solution of bupivacaine depending on the patient`s height and gestational age. The application of this method provided the development of the necessary degree of the sensory and motor block by the eight minute and created the requisite conditions for a cesarean section.Conclusion. The proposed method of the calculation of the hyperbaric solution dosage for subarachnoid anesthesia taking into account the patients` height and gestational age makes it possible to ensure the necessary degree of the sensor block at the level of 4-5 thoracic segments and suffcient relaxation in the surgical area during a cesarean section.

Publisher

Gomel State Medical University

Reference13 articles.

1. Arbatskaya NY. Gestational diabetes. News of Domestic Ppharmacy. 2021(1): 25-26. (In Russ.).

2. Bagomedow RG, Omarowa HM. Various types of anesthesia for cesarean section (literature review). Journal of New Medical Technologies. 2015;22(1):87-93. (In Russ.).

3. WHO. Global report on diabetes. Geneva: WHO; 2018. [Electronic resource]. [date of access 2021 May 17]. Available from: http://www.mif-ua.com/archive/article/5975

4. Dedov II, Shestakova MV. Personalized therapy for diabetes mellitus: the path from disease to the patient. Terapevticheskii arkhiv. 2014;86(10):4-9. (In Russ.)

5. Dedov II, Shestakova MV, Maksimova MA. Federal target program “Diabetes mellitus” [Electronic resource]: method. recommendations. M.: Media Sphere; 2002. [date of access 2021 May 17]. Available from: http://www.voed.ru/fcp_sd.htm (In Russ.).